Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,564.47
-8.3350-0.53%
Number of Gainers:1
Number of Losers:6
Number of Flat:- -
PE:- -
High:1,591.44
Open:1,573.14
Low:1,558.99
Close:1,572.81
Volume:60.44M
Turnover:4.79B
Market Cap:1.63T
Float Cap:1.57T

Loading ...

Novo Nordisk to Rebrand as Novo

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Dow Jones Top Company Headlines at 1 am ET: Biggest AI Rivals Agree They Need to Slow it Down | Amazon ...

Dow Jones
·
Sep 14

Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations with 21 Air After Miami Crash | Pfizer ...

Dow Jones
·
Sep 14

Pfizer Makes an Unusual Enemy in $2 Billion Fight over Unwanted Covid-19 Vaccines

Dow Jones
·
Sep 13

Pfizer Stock Eyes New Boom With Obesity And Alopecia Bets

TIPRANKS
·
Sep 12

Novo Nordisk Stock Slides as GLP-1 Fears Mount

TIPRANKS
·
Sep 12

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

ETF Weekly | MSTZ, SMST Surge 17%; AMUU, AMDL Jump 16%; USO Advances 9%; Oil Theme Gains

ETF Weekly
·
Sep 12

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

Sector Update: Healthcare

MT Newswires Live
·
Sep 12

Novo Nordisk Shares Fall After Morgan Stanley Downgrade

MT Newswires Live
·
Sep 12

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Sep 12

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 12

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Sep 11

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Sep 11

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Sep 11

Political and General News Events from September 11

Reuters
·
Sep 11

U.S. Stocks on the MOVE-Novo Nordisk, Oracle, Adobe

Reuters
·
Sep 11

Novo Nordisk Stock (NVO) Falls After Morgan Stanley’s Sell Call on Market Share Loss to Eli Lilly, Patent Cliff

TIPRANKS
·
Sep 11